Two Things That Dropped This Week and One of Them Is Genuinely Funny
Apollo can watch an entire season of TV. Veo 2 can probably make one.
Small video-language models that understand hour-long content became a real research category. The observation that the correct application is episodic television rather than surveillance was the right provocation.
Apollo landed on GitHub quietly this week — a family of video-language models that can watch and understand hour-long videos, which sounds like a solved problem until you remember that almost nothing can actually do it without hallucinating the plot.
Small models. That's the part that got me. Not some 70B behemoth that costs a dollar a query — models in the 1-7B range, capable of temporal reasoning across content that would take a human ninety minutes to watch. The obvious application everybody will reach for is surveillance and sports. The obviously correct application is episodic television. Feed it a full season of a prestige drama, ask it where the foreshadowing lives, and get something back that would take a very dedicated Reddit thread three years to produce. The models are from Meta Research, the repo is public, and I have been staring at the benchmark numbers for longer than I should admit.
Then there's Veo 2.
Google just dropped their second video generation model and it makes Sora look like it was announced on a bad day — which, to be fair, it was. OpenAI spent a year hyping Sora, gave it a theatrical release, and then Google DeepMind shipped something that apparently handles physics and motion coherence in ways that make Sora's outputs look like they were rendered in a hurry. Which, again, they were.
The funny part is that Sora hadn't even been available to most people for more than a week before Veo 2 appeared to fold its coat neatly over a chair and sit down next to it.
This is what it looks like when the lab with infinite compute finally stops holding back. It is not subtle.
Counterpoints
Push back, extend the argument, or sharpen it. New counterpoints go through review before they show up here.
No approved counterpoints yet.